Catherine Longworth

London

Healthcare Editor & Journalist @Healthcare_GD Tweeting about #Healthcare #Medtech #DigitalHealth Views my own Contact me: [email protected]

Featured in: Favicon

medicaldevice-network.com Favicon

informa.com (+1) Favicon

pharmaphorum.com Favicon

yourlocalguardian.co.uk Favicon

clinicaltrialsarena.com Favicon

bioworld.com Favicon

surreycomet.co.uk Favicon

wimbledonguardian.co.uk Favicon

wandsworthguardian.co.uk Favicon

kingstonguardian.co.uk + 3 more

Articles

Diversity commitment persists in clinical trials amidst policy shifts

2 weeks ago | clinicaltrialsarena.com | Catherine Longworth

Despite major policy rollbacks on diversity, equity, and inclusion (DEI) at the federal level, clinical research leaders have made it clear: inclusive research remains a top priority. Just days into his presidency, Donald Trump signed an executive order aimed at dismantling DEI initiatives across the federal government, with implications for private sector programs as well. However, the commitment to equitable clinical trial enrollment continues to evolve across the research sector.
Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025

2 weeks ago | pharmaceutical-technology.com | Catherine Longworth

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vösendorf, Austria on 24-25 November for in‑depth case studies, practical workshops and high‑impact networking designed to accelerate pharma’s digital journey.
London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine

2 weeks ago | pharmaceutical-technology.com | Catherine Longworth

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its debut. This year's event has significantly expanded its scope, offering an even richer array of content, product showcases, and innovations. May 20, 2025 Day 1 of the Biotechnology Show 2024. Image credit: Kate Darkins.
Examining shifts in clinical trial outsourcing

3 weeks ago | clinicaltrialsarena.com | Catherine Longworth

As clinical trials grow increasingly complex and globalised, industry leaders continue to reassess how outsourcing models can drive efficiency and innovation. These themes will be central at the 16th annual Outsourcing in Clinical Trials (OCT) East Coast conference, taking place May 20–21, 2025, at the Valley Forge Casino Resort in King of Prussia, Pennsylvania.
3D printing medical devices: industry unlocks new possibilities

2 months ago | medicaldevice-network.com | Catherine Longworth

As momentum continues to build, medical device companies are ramping up their investment in 3D printing technology. Driven by a strong focus on innovation and improving patient outcomes, the adoption of 3D printing services is rapidly expanding across the sector. According to GlobalData analysis, the medical 3D printing market is set to grow from a $2bn market in 2022 to $4bn in 2026 at a compound annual growth rate (CAGR) of 21%.
Features - Medical Device Network

Dec 2, 2024 | medicaldevice-network.com | Robert Barrie |Catherine Longworth |Jenna Philpott |Joshua Silverwood

Skip to site menuSkip to page content What’s next in prostate cancer detection technologies? With seven Olympic medals to his name – six of which are gold – Chris Hoy is one of the…
FDA LDT litigation could be ‘train wreck in the courts’

Oct 17, 2024 | finance.yahoo.com | Catherine Longworth

Litigation against the FDA's Final Rule on lab-developed tests (LDTs) is causing uncertainty to rise as the US regulator gears up for a legal clash with the lab industry. Since the FDA revealed its controversial Final Rule on LDTs, two laboratory associations have filed lawsuits which are now pending in one consolidated case in the U.S District Court for the Eastern District of Texas.
FDA LDT litigation could be 'train wreck in the courts'

Oct 17, 2024 | medicaldevice-network.com | Catherine Longworth
China Plus One? MedTech’s search for adaptable supply chain models

Oct 16, 2024 | finance.yahoo.com | Catherine Longworth

Device companies are establishing manufacturing operations outside of China to reduce dependence on Chinese manufacturing, but setting up facilities in "Plus One" countries is not without it's hurdles. During a panel discussion at AdvaMed’s The MedTech Conference in Toronto, supply chain leaders highlighted the risks and benefits of so called China Plus One (C+1) strategies.
Mobidiag Launches Automobi Joint Venture In China

Oct 15, 2024 | insights.citeline.com | Catherine Longworth

Mobidiag Launches Automobi Joint Venture In China03 Jun 2019 • By Catherine LongworthFinnish diagnostics company Mobidiag has launched its new joint venture with partner Autobio Diagnostics called Automobi.